AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke.
Related Research units
Abstract
Granulocyte colony-stimulating factor (G-CSF) is a promising stroke drug candidate. The present phase IIa study assessed safety and tolerability over a broad dose range of G-CSF doses in acute ischemic stroke patients and explored outcome data.
Bibliographical data
| Original language | German |
|---|---|
| Article number | 11 |
| ISSN | 0039-2499 |
| Publication status | Published - 2010 |
| pubmed | 20947859 |
|---|
